Product correctly added to cart.

×
Standards and Solutions in Compliance with Pharmacopoeias
Standards and Solutions in Compliance with Pharmacopoeias

Standards and Solutions in Compliance with Pharmacopoeias

Pharmacopoeias consist of a set of monographs on analytical procedures, specifications for the synthesis and quality control of medicinal products, excipients and active ingredients of medicinal products.
In CymitQuimica we have made an effort to unite in a single portal the standards of the most prestigious Pharmacopoeias:

- United States Pharmacopoeia (USP)
- European Pharmacopoeia (EP)
- British Pharmacopoeia (BP)
- Chinese Pharmacopoeia (CP)
- Japanese Pharmacopoeia (JP)

Check our categories just below to see complete product listings by pharmacopoeia.

Products of "Standards and Solutions in Compliance with Pharmacopoeias"

Sort by


See more categories

This search does not contain any category.

products per page. 4278 products on this category.

BrandProduct dataPurityPrice rangeEstimated delivery
EDQM - European Pharmacopoeia logo
Isoimperatorin
REF: 41-Y0002303CAS: 482-45-1
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Atorvastatin for peak identification B CRS
REF: 41-Y0002304
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Atorvastatin calcium CRS
REF: 41-Y0002315
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Atorvastatin for peak identification A CRS
REF: 41-Y0002319
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Thiopental impurity mixture - * psy (Pentobarbital)
REF: 41-Y0002320
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Verapamil impurity I CRS
REF: 41-V0100018CAS: 1794-55-4
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Amphotericin B RS
REF: 41-ICRS0210CAS: 1397-89-3
- - -107.00 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Flumequine impurity B CRS
REF: 41-F0189020
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Oxymatrine CRS
REF: 41-Y0002015CAS: 16837-52-8
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Alfuzosin for peak identification CRS
REF: 41-Y0001883CAS: 81403-68-1
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Sulfamethizole CRS
REF: 41-S2050000CAS: 144-82-1
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
-Acetyldigoxin CRS
REF: 41-Y0000565CAS: 5355-48-6
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Furosemide for peak identification CRS
REF: 41-Y0001493CAS: 54-31-9
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Estriol for system suitability CRS
REF: 41-Y0001971CAS: 50-27-1
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Chlortetracycline for system suitability CRS
REF: 41-Y0001451CAS: 64-72-2
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
All-rac-alpha-tocopheryl acetate for peak identification CRS
REF: 41-Y0000384CAS: 7695-91-2
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Caffeine for system suitability CRS
REF: 41-Y0000787CAS: 58-08-2
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Thiomersal CRS
REF: 41-Y0000109CAS: 54-64-8
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Fluspirilene impurity C CRS
REF: 41-Y0000375
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Oxeladin hydrogen citrate CRS
REF: 41-Y0000350CAS: 52432-72-1
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Heparin Low-Molecular-Mass for assay BRP
REF: 41-H0185000
- - -137.00 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Chlorcyclizine hydrochloride CRS
REF: 41-C1435000CAS: 14362-31-3
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Triclabendazole CRS
REF: 41-Y0001737CAS: 68786-66-3
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Folic acid RS
REF: 41-ICRS0316CAS: 59-30-3
- - -107.00 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Galantamine hydrobromide CRS
REF: 41-Y0001279CAS: 1953-04-4
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Glutathione CRS
REF: 41-Y0000517CAS: 70-18-8
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Nitrosotriaminopyrimidine CRS
REF: 41-N1000000CAS: 1006-23-1
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Acebutolol impurity B CRS
REF: 41-Y0000359
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Essential oil CRS
REF: 41-Y0000749CAS: 1993-14-2
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Rupatadine for system suitability CRS
REF: 41-Y0001919
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Ciclopirox olamine CRS
REF: 41-C2162700CAS: 41621-49-2
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Lovastatin CRS
REF: 41-L0790000CAS: 75330-75-5
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Ciprofibrate CRS
REF: 41-Y0000362CAS: 52214-84-3
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Enalapril impurity G CRS
REF: 41-Y0001829CAS: 10-33-3
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Allantoin CRS
REF: 41-A0349000CAS: 97-59-6
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Methylphenobarbital CRS - * psy
REF: 41-M1700000CAS: 115-38-8
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Oxymetazoline hydrochloride CRS
REF: 41-O0290000CAS: 2315-02-8
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Picrotoxinin CRS
REF: 41-Y0001528CAS: 17617-45-7
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Ticagrelor for system suitability CRS
REF: 41-Y0002223
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Epinastine for system suitability CRS
REF: 41-Y0001128CAS: 108929-04-0
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Fleeceflower root HRS
REF: 41-Y0001606
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Rubella vaccine (live) BRP
REF: 41-R2000000
- - -137.00 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Foscarnet impurity mixture CRS
REF: 41-Y0001213
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Oxycodone impurity D CRS
REF: 41-Y0000453CAS: 508-54-3
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Benserazide impurity C CRS
REF: 41-Y0001071
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Picrotin CRS
REF: 41-Y0001508CAS: 21416-53-5
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Ginsenoside Rg1 CRS
REF: 41-Y0002096CAS: 22427-39-0
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Digitoxin RS
REF: 41-ICRS0288CAS: 71-63-6
- - -107.00 €2 Feb 2022
EDQM - European Pharmacopoeia logo
2nd International Standard for Neomycin B
REF: 41-ISA_46104CAS: 28002-70-2
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Lamivudine CRS
REF: 41-Y0000425CAS: 134678-17-4
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Spectinomycin for system suitability CRS
REF: 41-Y0000549CAS: 22189-32-8
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Biotin for system suitability CRS
REF: 41-Y0001978CAS: 58-85-5
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Nicergoline CRS
REF: 41-Y0001373CAS: 27848-84-6
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Remifentanil hydrochloride CRS - * narc
REF: 41-Y0001892CAS: 132539-07-2
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Albendazole CRS
REF: 41-A0325100CAS: 54965-21-8
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Abacavir sulfate RS
REF: 41-ICRS1422CAS: 188062-50-2
- - -107.00 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Tricaprylin CRS
REF: 41-T1978000CAS: 538-23-8
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Atorvastatin impurity C CRS
REF: 41-Y0001330
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Tiaprofenic acid CRS
REF: 41-T1410900CAS: 33005-95-7
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Mirtazapine for system suitability CRS
REF: 41-Y0000721CAS: 61337-67-5
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Dalteparin sodium CRS
REF: 41-D0070000CAS: 9041-08-1
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Rivastigmine for system suitability CRS
REF: 41-Y0001485CAS: 129101-54-8
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Carprofen for system suitability CRS
REF: 41-Y0000884CAS: 53716-49-7
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Atorvastatin impurity E CRS
REF: 41-Y0001332
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Foeniculin for peak identification CRS
REF: 41-Y0000386CAS: 68952-43-2
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Levocarnitine impurity A CRS
REF: 41-L0399905CAS: 6538-82-5
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Indapamide CRS
REF: 41-I0150000CAS: 26807-65-8
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Sulfamethoxazole impurity A CRS
REF: 41-Y0000412CAS: 21312-10-7
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Carisoprodol impurity A CRS
REF: 41-Y0000036
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
2,4-Dichlorobenzyl alcohol impurity A CRS
REF: 41-Y0001621CAS: 34145-05-6
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Adrenaline impurity mixture CRS
REF: 41-Y0000740
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Alverine impurity D CRS
REF: 41-Y0000607
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Alfuzosin hydrochloride CRS
REF: 41-A0325800CAS: 81403-68-1
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Amobarbital sodium CRS - * psy
REF: 41-A0700000CAS: 64-43-7
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Riociguat for FP system suitability CRS
REF: 41-Y0002240
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Estradiol valerate CRS
REF: 41-Y0000046CAS: 979-32-8
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Amorolfine for system suitability CRS
REF: 41-Y0001795CAS: 78613-38-4
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Acebutolol impurity C CRS
REF: 41-Y0000127CAS: 40188-45-2
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Zuclopenthixol impurity B CRS
REF: 41-Y0000083
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Hydroxychloroquine sulfate CRS
REF: 41-Y0001839CAS: 747-36-4
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Ifosfamide impurity B CRS
REF: 41-I0060004CAS: 3464-14-2
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Tibolone - reference spectrum
REF: 41-Y0000748
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Selamectin CRS
REF: 41-Y0000814CAS: 165108-07-6
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Albendazole for system suitability CRS
REF: 41-Y0001964
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Pirfenidone CRS
REF: 41-Y0001769CAS: 53179-13-8
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Nomegestrol acetate impurity B CRS
REF: 41-Y0002169CAS: 58691-88-6
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Paraffin (liquid) - reference spectrum
REF: 41-Y0000058
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Doxazosin impurity F CRS
REF: 41-Y0000552CAS: 23680-84-4
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Lamotrigine for peak identification CRS
REF: 41-Y0001031CAS: 84057-84-1
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Atorvastatin calcium trihydrate CRS
REF: 41-Y0001327CAS: 344423-98-9
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Allopurinol impurity D CRS
REF: 41-A0350040CAS: 6994-25-8
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Nadroparin calcium CRS
REF: 41-N0025000CAS: 37270-89-6
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Acarbose for peak identification CRS
REF: 41-Y0000427CAS: 56180-94-0
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Felypressin CRS
REF: 41-Y0000415CAS: 56-59-7
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Gentamicin for peak identification CRS
REF: 41-Y0001363CAS: 1405-41-0
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Betamethasone dipropionate for system suitability A CRS
REF: 41-Y0001925CAS: 5593-20-4
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Chlorprothixene for system suitability CRS
REF: 41-Y0002088
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Oxfendazole with impurity D CRS
REF: 41-Y0000225CAS: 53716-50-0
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Dexamfetamine sulfate CRS - * narc
REF: 41-Y0002072CAS: 51-63-8
- - -118.99 €2 Feb 2022
EDQM - European Pharmacopoeia logo
Azithromycin impurity A CRS
REF: 41-Y0000307
- - -118.99 €2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Verapamil impurity I CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Amphotericin B RS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Alfuzosin for peak identification CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Sulfamethizole CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

-Acetyldigoxin CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Furosemide for peak identification CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Chlortetracycline for system suitability CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Caffeine for system suitability CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Thiomersal CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Oxeladin hydrogen citrate CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Chlorcyclizine hydrochloride CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Triclabendazole CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Folic acid RS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Galantamine hydrobromide CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Glutathione CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Nitrosotriaminopyrimidine CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Essential oil CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Ciclopirox olamine CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Lovastatin CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Ciprofibrate CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Allantoin CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Methylphenobarbital CRS - * psy

Controlled Product
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Oxymetazoline hydrochloride CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Picrotoxinin CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Epinastine for system suitability CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Oxycodone impurity D CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Picrotin CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Digitoxin RS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Lamivudine CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Spectinomycin for system suitability CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Nicergoline CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Remifentanil hydrochloride CRS - * narc

Controlled Product
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Albendazole CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Abacavir sulfate RS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Atorvastatin impurity C CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Tiaprofenic acid CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Mirtazapine for system suitability CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Dalteparin sodium CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Rivastigmine for system suitability CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Carprofen for system suitability CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Atorvastatin impurity E CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Indapamide CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Sulfamethoxazole impurity A CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

2,4-Dichlorobenzyl alcohol impurity A CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Adrenaline impurity mixture CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Alfuzosin hydrochloride CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Amobarbital sodium CRS - * psy

Controlled Product
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Estradiol valerate CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Amorolfine for system suitability CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Acebutolol impurity C CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Zuclopenthixol impurity B CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Hydroxychloroquine sulfate CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Ifosfamide impurity B CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Selamectin CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Pirfenidone CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Doxazosin impurity F CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Lamotrigine for peak identification CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Atorvastatin calcium trihydrate CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Allopurinol impurity D CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Acarbose for peak identification CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Felypressin CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Gentamicin for peak identification CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label

Betamethasone dipropionate for system suitability A CRS


Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022
discount label
Estimated delivery in United States, on Wednesday 2 Feb 2022

Thank you!

Welcome to CymitQuimica!Please accept the use of cookies to have a better experience on our website.

Cookies are important for you, they influence your browsing experience, they help us to protect your privacy and allow us to proceed with the requests that you demand through this website. We use our own and third-party cookies to analyze our services and provide you with advertising related to your preferences on the basis of a profile made from your browsing habits (for example, visited pages). If you consent to its installation, click on "Accept Cookies", or you can also set your preferences by clicking "Show cookie settings". More information is available in our Cookies Policy.